The rise of Viagra and its influence on the medicinal landscape presents a intricate question for traders. While the early sales data were impressive, the exclusivity has ended, leading to a flood of generic alternatives that are reducing revenue. Moreover, the market is facing issues related to aging trends and evolving healthcare regulations, mak